Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) Debt to equity

Alert me on Debt to equity

Abbott Laboratories's debt to equity at the end of the quarter to 30 June 2026 was 0.6×, up 0.4× from fiscal 2025 (0.2×). Over the past ten years it has ranged from 0.2× (fiscal 2025) to 1.0× (fiscal 2016) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.2× (16.92%)
FY2024 0.3× (22.00%)
FY2023 0.4× (16.81%)
FY2022 0.5× (9.30%)
FY2021 0.5× (10.77%)
FY2020 0.6× (2.01%)
FY2019 0.6× (9.09%)
FY2018 0.6× (29.27%)
FY2017 0.9× (10.73%)
FY2016 1.0× 262.53%

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.6× (2.48%)
Mar 2026 0.6× 163.67%
Dec 2025 0.2× (2.93%)
Sep 2025 0.3× (4.54%)
42 more quarters

Against its own ten years

Low 0.2× High 1.0×
Ten-year median 0.5×
Current reading's percentile 9

Debt to equity against peers

Company Debt to equity
EW Edwards Lifesciences Corporation compare 0.1×
STE STERIS plc compare 0.3×
DXCM DexCom, Inc. compare 0.5×
BSX Boston Scientific Corporation compare 0.5×
PHG Koninklijke Philips N.V. compare 0.6×
MDT Medtronic PLC compare 0.6×
SYK Stryker Corporation compare 0.6×
ABT Abbott Laboratories 0.6×
GEHC GE HealthCare Technologies Inc. compare 1.0×
Medical Devices industry median 0.1×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on ABT